vs
CareDx, Inc.（CDNA）与OneStream, Inc.（OS）财务数据对比。点击上方公司名可切换其他公司
OneStream, Inc.的季度营收约是CareDx, Inc.的1.4倍（$163.7M vs $117.7M），CareDx, Inc.净利率更高（2.4% vs 0.6%，领先1.8%），CareDx, Inc.同比增速更快（39.0% vs 23.6%），OneStream, Inc.自由现金流更多（$25.6M vs $514.0K），过去两年OneStream, Inc.的营收复合增速更高（21.8% vs 12.9%）
CareDx是一家专注于器官移植领域的精准医疗企业，核心产品包括移植排斥反应监测诊断试剂、数字健康管理工具及配套临床服务，面向北美和欧洲市场的医疗机构及移植患者，助力提升术后患者生存质量。
Blue Stream面向美国佛罗里达州科勒尔斯普林斯、韦斯顿两地的居民及商业客户，提供有线电视、有线固话、数字录像服务，以及最高速率达1G的宽带互联网接入服务，深耕当地通信市场，为用户提供稳定可靠的多元通信解决方案。
CDNA vs OS — 直观对比
营收规模更大
OS
是对方的1.4倍
$117.7M
营收增速更快
CDNA
高出15.4%
23.6%
净利率更高
CDNA
高出1.8%
0.6%
自由现金流更多
OS
多$25.1M
$514.0K
两年增速更快
OS
近两年复合增速
12.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $117.7M | $163.7M |
| 净利润 | $2.8M | $999.0K |
| 毛利率 | — | 69.8% |
| 营业利润率 | 1.0% | -3.2% |
| 净利率 | 2.4% | 0.6% |
| 营收同比 | 39.0% | 23.6% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.05 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDNAOS
| Q1 26 | $117.7M | — | ||
| Q4 25 | $108.4M | $163.7M | ||
| Q3 25 | $100.1M | $154.3M | ||
| Q2 25 | $86.7M | $147.6M | ||
| Q1 25 | $84.7M | $136.3M | ||
| Q4 24 | $86.6M | $132.5M | ||
| Q3 24 | $82.9M | $129.1M | ||
| Q2 24 | $92.3M | $117.5M |
净利润CDNAOS
| Q1 26 | $2.8M | — | ||
| Q4 25 | $-4.1M | $999.0K | ||
| Q3 25 | $1.7M | $-8.8M | ||
| Q2 25 | $-8.6M | $-18.4M | ||
| Q1 25 | $-10.4M | $-24.0M | ||
| Q4 24 | $87.7M | — | ||
| Q3 24 | $-10.6M | $-171.9M | ||
| Q2 24 | $-4.6M | $-7.8M |
毛利率CDNAOS
| Q1 26 | — | — | ||
| Q4 25 | — | 69.8% | ||
| Q3 25 | — | 68.1% | ||
| Q2 25 | — | 68.6% | ||
| Q1 25 | — | 68.0% | ||
| Q4 24 | — | 66.8% | ||
| Q3 24 | — | 50.1% | ||
| Q2 24 | — | 68.5% |
营业利润率CDNAOS
| Q1 26 | 1.0% | — | ||
| Q4 25 | -5.6% | -3.2% | ||
| Q3 25 | -0.2% | -11.3% | ||
| Q2 25 | -12.8% | -21.8% | ||
| Q1 25 | -15.8% | -29.3% | ||
| Q4 24 | 97.5% | -35.8% | ||
| Q3 24 | -16.6% | -197.6% | ||
| Q2 24 | -7.9% | -9.8% |
净利率CDNAOS
| Q1 26 | 2.4% | — | ||
| Q4 25 | -3.8% | 0.6% | ||
| Q3 25 | 1.7% | -5.7% | ||
| Q2 25 | -9.9% | -12.5% | ||
| Q1 25 | -12.2% | -17.6% | ||
| Q4 24 | 101.3% | — | ||
| Q3 24 | -12.8% | -133.1% | ||
| Q2 24 | -5.0% | -6.7% |
每股收益（稀释后）CDNAOS
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-0.08 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $-0.16 | — | ||
| Q1 25 | $-0.19 | — | ||
| Q4 24 | $1.60 | — | ||
| Q3 24 | $-0.20 | $-1.06 | ||
| Q2 24 | $-0.09 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.9M | $693.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $504.7M |
| 总资产 | $411.1M | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CDNAOS
| Q1 26 | $77.9M | — | ||
| Q4 25 | $177.2M | $693.6M | ||
| Q3 25 | $194.2M | $653.9M | ||
| Q2 25 | $186.3M | $652.1M | ||
| Q1 25 | $230.9M | $593.9M | ||
| Q4 24 | $260.7M | $544.2M | ||
| Q3 24 | $240.9M | $495.5M | ||
| Q2 24 | $228.9M | $140.5M |
总债务CDNAOS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — |
股东权益CDNAOS
| Q1 26 | — | — | ||
| Q4 25 | $303.1M | $504.7M | ||
| Q3 25 | $311.1M | $472.1M | ||
| Q2 25 | $327.4M | $458.2M | ||
| Q1 25 | $379.3M | $412.9M | ||
| Q4 24 | $378.4M | $386.2M | ||
| Q3 24 | $273.2M | $458.2M | ||
| Q2 24 | $264.7M | $97.5M |
总资产CDNAOS
| Q1 26 | $411.1M | — | ||
| Q4 25 | $413.2M | $1.0B | ||
| Q3 25 | $432.3M | $949.4M | ||
| Q2 25 | $444.3M | $910.5M | ||
| Q1 25 | $489.6M | $867.3M | ||
| Q4 24 | $491.1M | $823.2M | ||
| Q3 24 | $477.0M | $750.1M | ||
| Q2 24 | $466.8M | $379.7M |
负债/权益比CDNAOS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.3M | $25.8M |
| 自由现金流经营现金流 - 资本支出 | $514.0K | $25.6M |
| 自由现金流率自由现金流/营收 | 0.4% | 15.7% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | 1.54× | 25.79× |
| 过去12个月自由现金流最近4个季度 | — | $95.6M |
8季度趋势，按日历期对齐
经营现金流CDNAOS
| Q1 26 | $4.3M | — | ||
| Q4 25 | $21.4M | $25.8M | ||
| Q3 25 | $37.4M | $5.0M | ||
| Q2 25 | $9.9M | $29.7M | ||
| Q1 25 | $-26.6M | $36.2M | ||
| Q4 24 | $21.9M | — | ||
| Q3 24 | $12.5M | $2.4M | ||
| Q2 24 | $18.9M | $8.1M |
自由现金流CDNAOS
| Q1 26 | $514.0K | — | ||
| Q4 25 | — | $25.6M | ||
| Q3 25 | — | $4.8M | ||
| Q2 25 | — | $29.4M | ||
| Q1 25 | — | $35.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $7.7M |
自由现金流率CDNAOS
| Q1 26 | 0.4% | — | ||
| Q4 25 | — | 15.7% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 19.9% | ||
| Q1 25 | — | 26.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 6.6% |
资本支出强度CDNAOS
| Q1 26 | — | — | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.3% |
现金转化率CDNAOS
| Q1 26 | 1.54× | — | ||
| Q4 25 | — | 25.79× | ||
| Q3 25 | 22.30× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CDNA
| Financial Results Total | $85.0M | 72% |
| Patient and digital solutions revenue | $16.0M | 14% |
| Product revenue | $10.3M | 9% |
| Other | $6.4M | 5% |
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
